IQVIA™ Real-World Insights Bibliography

Characterisation of Pulmonary Arterial Hypertension (PAH) Patients Initiating a New PAH Specific Therapy in the Context of Age: Insights from EXPOSURE
Author(s): P. Escribano (1), S. Gaine (2), P. Biedermann (3), A. Muller (3), M. Valge (4), T. Lange (5), S. Söderberg (6)
Affiliations(s): 1 Pulmonary Hypertension Unit, Cardiology Department, CIBERCV, Hospital 12 de Octubre, Madrid, Spain 2 National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland 3 Actelion Pharmaceuticals Ltd, Allschwil, Switzerland 4 StatFinn Estonia OÜ, Tartu, Estonia (now IQVIA) 5 University Medical Center Regensburg, Regensburg, Germany 6 Department of Public Health and Clinical Medicine, Cardiology and Heart Centre, Umeå University, Umeå, Sweden
Publication(s):  JO - The Journal of Heart and Lung Transplantation VL - 40 IS - 4, Supplement SP - S109 PY - 2021 DA - 2021/04/01/ SN - 1053-2498
Document Type(s): Abstract,
Countries: Canada, Europe,
Click here for the abstract
C:
Y:
Cardiovascular disease,
2021
  L:
A:
English
Epidemiological study, Observational study,
  Add to report
 
 
Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer
Author(s): Gomez-Ulloa D1, Amonkar M2, Kothari S3, Cheung WY4, Chau I5, Zalcberg J6, Lara N1, Falcone A7
Affiliations(s): 1 IQVIA, Barcelona, Spain 2 Merck & Co., Inc., North Wales, PA, US 3 Merck & Co., Inc., Kenilworth, NJ, US 4 British Columbia Cancer Agency, Vancouver, BC, Canada 5 Royal Marsden Hospital, London, UK 6 Alfred Health, Melbourne, Australia 7 University of Pisa, Pisa, Italy
Publication(s):  BMC Gastroenterology
BMC Gastroenterology volume 20, Article number: 133 (2020)
Document Type(s): Article,
Countries: Australia, Canada, Italy, UK,
Click here for the abstract
C:
Y:
Oncology,
2020
  L:
A:
English
Retrospective cohort analysis,
  Add to report
 
 
Patient preferences, treatment satisfaction, and quality of life in newly diagnosed and relapsed/refractory multiple myeloma patients receiving injectable-containing or fully oral therapies: the EASEMENT study
Author(s): Neil Rabin1, Rami Kotb2, Athanasios Zomas3, Alonso Fernandez-Nistal3, Rocco D?Ambrosio3, Nawal Bent-Ennakhil3, Montserrat Roset4, Ombretta Annibali5
Affiliations(s): 1 University College London Hospitals, London, and North Middlesex University Hospital, UK; 2 CancerCare Manitoba, Winnipeg, Manitoba, Canada; 3 Takeda Pharmaceuticals International AG, Zurich, Switzerland; 4 IQVIA, Barcelona, Spain; 5 Università Campus Bio-Medico di Roma, Rome, Italy
Publication(s):  COMy (the 6th World Congress on Controversies in Multiple Myeloma), Virtual congress, 3-4 October 2020
Document Type(s): Poster,
Countries: Canada, Italy, UK,
C:
Y:
Hematology, Oncology,
2020
  L:
A:
English
Population Based Study,
  Add to report
 
 
Quantifying the burden of the treatment-resistant depression in Ontario: Shredding light on an inportant mental health issue
Author(s): Brad Millson, G Sarah Power, Dr. Roger S. McIntyre
Affiliations(s): Brad Millson, G Sarah Power, IQVIA RWE team
Publication(s):  CADTH 2020
Document Type(s): Article,
Countries: Canada,
Click here for the abstract
C:
Y:
Health status & patient reported outcomes, Mental health,
2020
  L:
A:
English
Retrospective cohort analysis,
  Add to report
 
 
A Retrospective Observational Cohort study to Assess the Prevalence of Diabetic Kidney Disease Among Type 2 Diabetes Patients in Ontario, Canada
Author(s): Wally Rapattoni, David Zante, Ali Tehrani, Varun Myageri, Shane Golden, Brad Millson, Sheldon W. Tobe, Jennifer B. Rose
Affiliations(s): Ali Tehrai, Varun Myageri, shane Golden, Brad Millson
Publication(s):  ERA - EDRA Virtual Congress June 6-9 2020
Document Type(s): Poster,
Countries: Canada,
Click here for the abstract
C:
Y:
Diabetes, Public Health,
2020
  L:
A:
English
Clinical setting: hospital, Clinical setting: Primary care, Cost analysis, direct-to-patient research, Observational study, Retrospective cohort analysis,
  Add to report
 
 
Patient characteristics and treatment patterns in multiple myeloma by treatment administration route and disease status: EASEMENT observational study
Author(s): Rabin N1, Kotb R2, Zomas A3, Gonzalez F3, Fernandez-Nistal A3, D?Ambrosio R3, Bent-Ennakhil N3, Roset M4, Annibali O5
Affiliations(s): 1 University College Hospital, London, UK 2 Cancer Care Manitoba, Canada 3 Takeda Pharmaceuticals International AG, Switzerland 4 IQVIA, Barcelona, Spain 5 Università Campus Bio-Medico di Roma, Italy
Publication(s):  IMW, Boston, US, 12-15 September 2019
Document Type(s): Poster,
Countries: Canada, Italy, UK,
Click here for the abstract
C:
Y:
Clinical practice, Hematology,
2019
  L:
A:
English
Epidemiological study, Observational study,
  Add to report
 
 
The clinical and cost impact of switching to fingolimod versus other first line injectable disease-modifying therapies in patients with relapsing multiple sclerosis
Author(s): Freedman MS1, Duquette P2, Grand'Maison F3, Lee L4, Vorobeychik G5, Lara N6, Khurana V7, Nakhaipour HR8, Schecter R8, Haddad P8
Affiliations(s): 1 University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada 2 Notre Dame Hospital, Université de Montréal, Montreal, Quebec , Canada 3 Neuro-Rive Sud Clinic , Greenfield Park , Quebec , Canada 4 Sunnybrook Health Sciences Centre , University of Toronto , Toronto , Ontario , Canada 5 Fraser Health Multiple Sclerosis Clinic Burnaby Hospital , Burnaby , British Columbia , Canada 6 IQVIA , Barcelona , Spain 7 Novartis Healthcare Private Limited , Hyderabad , India 8 Novartis Pharmaceuticals Canada Inc., Dorval, Quebec, Canada
Publication(s):  Curr Med Res Opin. 2019 May;35(5):767-776
Document Type(s): Article,
Countries: Canada,
Click here for the abstract
C:
Y:
Neurological disorders,
2019
  L:
A:
English
Burden of illness, Retrospective Field Study,
  Add to report
 
 
Real-world treatment patterns and clinical outcomes in patients receiving second-line (2L) treatment for advanced or metastatic gastric cancer (GC)
Author(s): Amonkar M1, Gomez-Ulloa D2, Smita Kothari1, Cheung WY3, Chau I4, Zalcberg JR5, Lara N2, Falcone A6
Affiliations(s): 1 Merck & Co., Inc., Kenilworth, NJ, USA 2 IQVIA, Barcelona, Spain 3 British Columbia Cancer Agency, Vancouver, BC, Canada 4 Royal Marsden Hospital, London, UK 5 Alfred Health, Melbourne, Australia 6 University of Pisa, Pisa, Italy
Publication(s):  BMC Gastroenterology volume 20, Article number: 133 (2020)
Document Type(s): Poster,
Countries: Australia, Canada, Italy, UK,
C:
Y:
Oncology,
2019
  L:
A:
English
Retrospective cohort analysis,
  Add to report
 
 
GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data.
Author(s): Divino V, Boye KS, Lebrec J, DeKoven M, Norrbacka K
Affiliations(s): IQVIA, Eli Lilly
Publication(s):  Journal. Diabetes Ther. 2019 Jun;10(3):1067-1088.
Document Type(s): Article,
Countries: Belgium, Canada, France, Germany, Italy, Netherlands ,
Click here for the abstract
C:
Y:
Diabetes,
2019
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
A population-based analysis of anti-diabetic medications in four Canadian provinces: secular trends and prescribing patterns
Author(s): Secrest MH, Azoulay L, Dahl M, Clemens KK, Durand M, Hu N, Targownik L, Turin TC, Dormuth CR, and Filion KB
Affiliations(s): IQVIA, Cambridge, MA
Publication(s):  Pharmacoepidemiology & Drug Safety (in press)
Document Type(s): Article, In press/to be published,
Countries: Canada,
C:
Y:
Diabetes, Drug Utlization Study,
2019
  L:
A:
English
Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis,
  Add to report
 
 
 1 of 12 Next Page Last Page